µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© c0Ro3j\p
h
Io S#]
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ( WtE`f;Q
1¡¢Co-stimulators (or co-stimulating molecules) 1S]gD&V
2¡¢NK-kB f(s3TLM
3¡¢Immunoglobulin superfamily dzE Q$u/I
4¡¢antigen-presenting cell (APC) Dw/Gha/
5¡¢death domain xnuv4Z}]t
6¡¢CCR and CXCR <Dj$0g
7¡¢Lectin (or mitogen) =
EChH@3
8¡¢Clusters of differentiation, CD) /xm#:+Sc
9¡¢B7 family s.I1L?s1w?
10¡¢Cytotoxic T lymphocyte, CTL) a.dxgW[
11¡¢IL-15 and IL-15 receptor (IL-15R) s!;VUr\
12¡¢MHC restriction .Uh
BvHH
13¡¢Affinity-chromatography +=*m! 7Mr
14¡¢Cyctosprin A, CsA
6:@t=C
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) &Wz`>qYL*
|RAQ% VXm
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© rq(~/Yc
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 1S[5#ewB;j
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ q4.dLU,1
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 ]D) 'I`
R|)2Dg
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© Y zBA{FE
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ F@K*T2uh
ѪҺ²¡Ñ§×¨Òµ£º >SxZ9T|%
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿